Upper GI 2016

PRE-OPERATIVE treatments improve OS

N population

Type

mOS (months)

3-year Survival (%)

Kelsen, 1998

440 46% SCC 54% ADC 802 31% SCC 69% adc

Surg +/- CT

14.9 vs 16.1

26 vs 23

MRC, 2002 Allumet, 2009

Surg +/- CT

13.3 vs 16.8

17 vs 23 (5 yrs)

✔

Cunningham,

503 74%adc gastr

Surg +/-

NR

23 vs 36

✔

2006

26%adc oeso CT périopératoire

(5 yrs)